OpenLB
Open Library of Bioscience
Advanced Search
Healthcare (Basel, Switzerland)
Sep 20, 2023;11 (18):

Role of Trust, Risk Perception, and Perceived Benefit in COVID-19 Vaccination Intention of the Public.

Siu-Shing Man, Huiying Wen, Ligao Zhao, Billy Chun-Lung So
Author Information
  1. Siu-Shing Man: School of Design, South China University of Technology, Guangzhou 510641, China. ORCID
  2. Huiying Wen: School of Design, South China University of Technology, Guangzhou 510641, China. ORCID
  3. Ligao Zhao: Guangzhou Huadu Huacheng Community Health Service Centre, Guangzhou 510810, China.
  4. Billy Chun-Lung So: Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong, China. ORCID
PMID: 37761786 DOI: 10.3390/healthcare11182589

Abstract

COVID-19 vaccination is an effective method for dealing with the COVID-19 pandemic. This study proposed and validated a theoretical intention model for explaining the COVID-19 vaccination intention (CVI) of the public. The theoretical intention model incorporated trust in vaccines, two types of risk perception (risk perception of COVID-19 and risk perception of COVID-19 vaccination), and perceived benefit into a theory of planned behavior (TPB). Structural equation modeling was utilized to test the theoretical intention model with data collected from 816 Chinese adults in China. The results confirmed the crucial role of trust in vaccines, risk perception, and perceived benefit in shaping the CVI of the public. In addition, TPB was found to be applicable in a research context. The theoretical intention model accounted for 78.8% of the variance in CVI. Based on the findings, several practical recommendations for improving COVID-19 vaccination rates were discussed.

Keywords

COVID-19 vaccination intention perceived benefit risk perception theory of planned behavior trust

References

  1. Vaccine. 2015 Aug 14;33(34):4215-7 [PMID: 25896378]
  2. Arch Microbiol. 2021 Dec 6;204(1):8 [PMID: 34873656]
  3. Health Commun. 2022 Oct;37(11):1423-1431 [PMID: 33685304]
  4. J Exp Psychol Appl. 2021 Dec;27(4):599-620 [PMID: 35073128]
  5. N Engl J Med. 2020 Dec 3;383(23):2202-2204 [PMID: 32897660]
  6. Am J Health Promot. 2022 Jan;36(1):175-179 [PMID: 34164998]
  7. Vaccine. 2019 Feb 8;37(7):945-955 [PMID: 30655176]
  8. Int J Environ Res Public Health. 2022 Aug 02;19(15): [PMID: 35954864]
  9. BMC Med. 2021 Nov 17;19(1):281 [PMID: 34784922]
  10. Int Braz J Urol. 2020 Jul;46(suppl.1):120-124 [PMID: 32550706]
  11. J Safety Res. 2019 Dec;71:25-39 [PMID: 31862036]
  12. Int J Environ Res Public Health. 2021 May 11;18(10): [PMID: 34064920]
  13. Eur J Epidemiol. 2020 Aug;35(8):775-779 [PMID: 32785815]
  14. Am J Transplant. 2021 Apr;21(4):1650-1656 [PMID: 33788992]
  15. Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621 [PMID: 33242386]
  16. Disabil Health J. 2022 Jan;15(1):101223 [PMID: 34663563]
  17. Engineering (Beijing). 2022 Mar;10:127-132 [PMID: 35096437]
  18. Patient Educ Couns. 2022 Jul;105(7):2248-2255 [PMID: 35216853]
  19. Vaccines (Basel). 2021 Aug 29;9(9): [PMID: 34579204]
  20. Front Psychol. 2020 Oct 29;11:592246 [PMID: 33250830]
  21. Nat Hum Behav. 2021 Mar;5(3):337-348 [PMID: 33547453]
  22. Nat Med. 2021 Aug;27(8):1338-1339 [PMID: 34272500]
  23. EClinicalMedicine. 2020 Sep;26:100495 [PMID: 32838242]
  24. Patient Educ Couns. 2022 Feb;105(2):277-283 [PMID: 34565643]
  25. J Environ Manage. 2022 Jan 15;302(Pt B):114085 [PMID: 34800764]
  26. Int J Mol Epidemiol Genet. 2021 Jun 15;12(3):35-39 [PMID: 34336136]
  27. Int J Infect Dis. 2020 Oct;99:312-323 [PMID: 32768695]
  28. N Engl J Med. 2020 Apr 30;382(18):e41 [PMID: 32212516]
  29. Front Psychol. 2021 Jun 16;12:648289 [PMID: 34220620]
  30. Vaccine. 2022 Jan 3;40(1):100-106 [PMID: 34839994]
  31. Vaccine. 2020 Nov 10;38(48):7668-7673 [PMID: 33071002]
  32. Soc Sci Med. 2003 Apr;56(7):1453-68 [PMID: 12614697]
  33. Hum Vaccin Immunother. 2021 Oct 3;17(10):3322-3332 [PMID: 34137670]
  34. Vaccines (Basel). 2020 Aug 27;8(3): [PMID: 32867224]
  35. Psychol Health Med. 2021 Jan;26(1):1-12 [PMID: 32479113]
  36. Patient Educ Couns. 2022 Aug;105(8):2771-2777 [PMID: 35393230]
  37. Risk Manag Healthc Policy. 2021 Jun 21;14:2609-2623 [PMID: 34188572]
  38. Vaccines (Basel). 2021 Jul 21;9(8): [PMID: 34451935]
  39. J Obstet Gynaecol Res. 2019 Dec;45(12):2440-2451 [PMID: 31475426]
  40. Hematol Transfus Cell Ther. 2022 Jan-Mar;44(1):70-75 [PMID: 34541459]
  41. Am J Infect Control. 2021 Feb;49(2):137-142 [PMID: 33227323]
  42. Psychol Health Med. 2022 Jan;27(1):150-161 [PMID: 34555955]
  43. Br J Health Psychol. 2020 Nov;25(4):1039-1054 [PMID: 32889759]
  44. Psychol Health. 2022 Sep;37(9):1111-1131 [PMID: 34180333]
  45. Nat Hum Behav. 2021 Jul;5(7):947-953 [PMID: 33972767]
  46. R Soc Open Sci. 2020 Sep 16;7(9):200742 [PMID: 33047037]
  47. PLoS One. 2011 Mar 11;6(3):e17713 [PMID: 21412418]
  48. Diseases. 2022 Nov 17;10(4): [PMID: 36412598]
  49. Diabetes Metab Syndr. 2021 May-Jun;15(3):1017-1022 [PMID: 34000711]
  50. Int J Environ Res Public Health. 2022 Feb 10;19(4): [PMID: 35206141]
  51. Front Public Health. 2021 Jul 01;9:700213 [PMID: 34277557]
  52. Public Health. 2021 Sep;198:200-207 [PMID: 34481275]
  53. Milbank Q. 2001;79(4):613-39, v [PMID: 11789119]
  54. Infect Dis Ther. 2020 Sep;9(3):467-480 [PMID: 32583334]
  55. BMC Public Health. 2019 Apr 25;19(1):434 [PMID: 31023306]
  56. Hum Vaccin Immunother. 2021 Oct 3;17(10):3413-3420 [PMID: 34170792]
  57. JMIR Public Health Surveill. 2020 Sep 1;6(3):e20572 [PMID: 32755882]
  58. Soc Sci Med. 2017 Nov;193:70-79 [PMID: 29028558]
  59. Psychol Health Med. 2022 Dec;27(10):2171-2178 [PMID: 34875946]
  60. Vaccine. 2021 Sep 24;39(40):6004-6012 [PMID: 33160755]
  61. Vaccine. 2019 Feb 21;37(9):1168-1173 [PMID: 30709722]
  62. Aust N Z J Public Health. 2022 Feb;46(1):16-24 [PMID: 34897909]
  63. Vaccine. 2021 Feb 5;39(6):994-999 [PMID: 33423839]
  64. Emotion. 2021 Apr;21(3):478-488 [PMID: 32271047]
  65. J Clin Med. 2020 Feb 21;9(2): [PMID: 32098019]
  66. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-8 [PMID: 34715009]
  67. J Safety Res. 2021 Dec;79:329-340 [PMID: 34848013]
  68. Vaccine. 2021 Jan 8;39(2):247-254 [PMID: 33328140]
  69. Hum Vaccin Immunother. 2021 Dec 2;17(12):4806-4815 [PMID: 34892992]
  70. Public Health. 2020 Oct;187:8-14 [PMID: 32866818]
  71. Vaccines (Basel). 2021 Jun 22;9(7): [PMID: 34206226]
Journal Article

Word Cloud

Created with Highcharts 10.0.0COVID-19intentionvaccinationriskperceptiontheoreticalmodelCVItrustperceivedbenefitpublicvaccinestheoryplannedbehaviorTPBeffectivemethoddealingpandemicstudyproposedvalidatedexplainingincorporatedtwotypesStructuralequationmodelingutilizedtestdatacollected816ChineseadultsChinaresultsconfirmedcrucialroleshapingadditionfoundapplicableresearchcontextaccounted788%varianceBasedfindingsseveralpracticalrecommendationsimprovingratesdiscussedRoleTrustRiskPerceptionPerceivedBenefitVaccinationIntentionPublic

Similar Articles

Cited By